Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by aussyspitzon May 10, 2020 9:29am
118 Views
Post# 31008644

RE:RE:The irons in the fire have diminished considerably.

RE:RE:The irons in the fire have diminished considerably.
"A little delay because of corona virus" and therein lies the problem this company, the management and Thomson have been dangling the proverbial "BLA for Ryplazim and Partnership Carrot" in front of the same old tired donkey cart for a pretty longtime. After over 25 years of pulling the shyt cart they butchered the old donkeys but I'm glad to see there are some new donkeys i.e. newstockyjohnson and whomever else they can sucker in that are willing to continue to pull that same old shyt cart with a new coat of paint for them. 

If they announce any delay regarding either the partnership or BLA or the need to raise additional capital it will further erode the share price at the analyst 12 month target of $9.20 CAD you are looking at an approx 40% loss of your investment if you bought at the rights offering price not to mention the opportunity cost of what could end up being a minimum of 2 years.

You could staple angels wings to this pig and imo it still wouldn't fly. If you have had your eyes wide open all this time and own shares of this already then by all means it makes sense to hold on to your shares and wait to see what happens in the next few months. If you are looking to invest I would highly advise you just avoid this pig until after they have actually proven that they can accomplish anything that actually improves shareholder value before you hook your harness up to this cart. If as the pumpers say this triples on news to $33 and is $50 by eoy which I seriously doubt then there is still an opportunity to make a decent profit following news with significantly less risk.

Disclosure: I am not telling you to sell, I no longer own the stock, I am not bidding and/or buying this stock at any price and it is not because I hate the stock but because imo I think it is a very poor investmet vehicle that has and continues to be managed and operated unethically  
<< Previous
Bullboard Posts
Next >>